How Third Party Pharma Manufacturing Works in India

Third party pharma manufacturing is one of the most common ways a pharmaceutical brand gets made in India. The company whose name is on the pack does not own the plant; a licensed manufacturer produces the product on its behalf. If you are looking at starting your own range, or moving an existing one to a new partner, it helps to understand exactly what is being outsourced — and what is not.

What is actually being outsourced

In a third party arrangement the brand owner keeps the things that make the business valuable: the brand name, the artwork, the customer relationships and the market. What gets outsourced is production capacity — the plant, the equipment, the licence to manufacture, and the technical staff who run it.

That distinction matters commercially. You are not buying a product off a shelf; you are buying manufacturing capacity against your specification, and the resulting stock is yours to sell under your own label.

Contract manufacturing vs private labelling

The two terms get used loosely, but they describe different starting points:

• Contract manufacturing — you bring the formulation and specification. The manufacturer produces to your brief. This suits companies that already have a defined product or want something that is not in the manufacturer's range.
• Private labelling — you select from the manufacturer's existing catalogue and it is packed under your brand. This is faster and cheaper to start, because the formulation and packing material formats already exist.

Many new brands begin with private labelling to get to market quickly, then move selected products to contract manufacturing once volumes justify a dedicated formulation.

The licences each side needs

Manufacturing and selling medicines in India is governed by the Drugs & Cosmetics Act, 1940 and the Rules made under it. In broad terms:

• The manufacturer must hold a valid manufacturing licence for the categories being produced — typically Form 25 for general drugs and Form 28 for products specified in Schedules C and C(1).
• The brand owner must hold a valid drug licence and GST registration to have products manufactured and sold in its name.
• Both sides remain bound by the labelling requirements under the Rules — the pack must carry the mandatory declarations, and both parties are exposed if it does not.

Requirements vary by product category and by state, so confirm your specific position with your licensing authority rather than relying on a general article — including this one.

How an order actually moves

A typical order runs through a predictable sequence. Knowing it lets you tell a well-run partner from a disorganised one:

1. Requirement — you share products, compositions, pack sizes, quantities and target market.
2. Product selection — the manufacturer confirms what falls inside its licence and matches your brief to its range.
3. Quotation — a written rate per pack, the batch size, packing material costs and a committed lead time.
4. Artwork — you supply artwork; it should be reviewed against labelling requirements before anything is printed.
5. Production — the batch is manufactured under the technical staff named on the manufacturer's licence.
6. Quality check — in-process and finished-product checks before release.
7. Packing and dispatch — packed to your approved artwork and dispatched with batch documentation.

The artwork step is where most delays happen. Printing packing material before the artwork is checked is an expensive mistake, and reprinting a carton run is not a small cost.

What to check before you commit

• Ask to see the manufacturing licence and confirm it covers your product category — not just that one exists.
• Check the certificate numbers and validity dates on any quality certification, and confirm they are current.
• Ask who the named competent technical staff are; a licence names them for a reason.
• Get the lead time in writing with the quotation, not verbally afterwards.
• Be clear about who owns the formulation, especially if you are paying for development work.
• Establish what batch documentation you receive, because you will need it for your own records.

The commercial case

The reason third party manufacturing is so widespread is straightforward. Building and licensing a pharmaceutical plant is a large, slow capital commitment. Outsourcing production converts that into a variable cost per pack, lets you scale volumes up or down between orders, and keeps your capital in the part of the business you actually control — the market.

What it does not do is transfer responsibility. Your name is on the pack. Choose a partner whose paperwork you have actually read.